Introduction
The tight spatial and temporal coupling of neuronal activity with local cerebral blood flow (CBF), which is known as neurovascular coupling, is a hallmark of brain function (Magistretti et al., 1999; Iadecola, 2004) . Functional hyperemia occurs within seconds of neuronal activation and is spatially coupled to brain areas with increased energy demand (Chaigneau et al., 2003; Lauritzen, 2005) . Any damage to the neurovascular coupling mechanism is accompanied by disturbance of brain cell homeostasis and provokes brain pathology and cell death. Clarifying the key molecular targets underlying the regulation of neurovascular coupling and controlling them could present a consequential way of increasing the life of brain cells, overcoming neurodegenerative diseases, and delaying the process of senescence.
The commonly accepted hypothesis is that local vasodilation in response to neuronal activity depends on the activation of astrocytes by locally released neurotransmitters. Many biochemical substances mimic the role of triggers and key mediators of neurovascular coupling. However, the data are usually controversial, the major reason being that investigations of this life science phenomenon are based on indirect approaches. At least three biochemical pathways of astrocyte-mediated vasodilation act like triggers (Bakalova et al., 2002; Ances, 2004; Girouard and Iadecola, 2006; Phillis et al., 2006; Takano et al., 2006; Wang et al., 2006) : (i) arachidonic acid cascade; (ii) nitric oxide cascade; (iii) adenosine-mediated pathway. In addition, other substances such as Ca 2+ , H + , carbon dioxide, and carbon oxide are also related to the vasodilation pathway.
In the present study, we focused on the products of the arachidonic acid cascade as one of the critical triggers or secondary regulators of neurovascular coupling in the brain. Our reason for this was based mainly on the unique lipid composition of rat brain tissue. Approximately 90% of rat brain cell membranes of synapses and astrocytes consist only of polyunsaturated lipids, composed of arachidonic acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) residues (Kagan et al., 1992; Chalon et al., 2001; Yehuda et al., 2002; Solfrizzi et al., 2005) . There are no other animal tissues with such lipid composition. Arachidonic acid is a precursor of prostaglandins, DHA of docosanoids, and EPA of eicosanoids. It is well known that all neurodegenerative diseases are accompanied by a significant decrease of these polyunsaturated fatty acids (PUFAs) in the brain, as well as by an imbalance in their metabolites (Kagan et al., 1992; Yehuda et al., 2002; Solfrizzi et al., 2005) . Therefore, the metabolites of PUFAs could be selected as priority molecular targets in investigations of the regulatory mechanisms of neurovascular coupling. However, it is necessary to note that the reason for the unique lipid composition of brain Neuroscience Research 65 (2009) [64] [65] [66] [67] [68] [69] [70] The present study was designed to clarify the precision of the main approach for investigating the regulation of local cerebral blood flow (CBF) response to neuronal activation in the brain (neurovascular coupling). In this study, we examined the effects of NS-398, a highly selective cyclooxygenase-2 inhibitor, on the physiological variables, baseline CBF, and local CBF response during rat somatosensory neuronal activation by laser-Doppler flowmetry. Blood pressure and heart rate were significantly decreased 3 h after i.v. infusion of NS-398. Baseline CBF and local CBF during somatosensory activation gradually decreased with an increase in time of NS-398 infusion up to 3 h, although neuronal activity in the somatosensory area was almost constant during the infusion. The results suggest that cyclooxygenase-2 participates in the regulation of local CBF during neuronal activation in rats. The present study also revealed the potential side-effects of dimethylsulfoxide, a solvent of NS-398, on neurovascular coupling.
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